Drug reclassification issue is re-highlighted

Published: 2011-02-10 06:57:00

Updated: 2011-02-10 06:57:00

The debate for the drug reclassification plan is resurfacing as 25 civic groups here are joining hands to press ahead with a campaign for the sale of nonprescription drugs at convenience stores.

In a seminar held in the Fair Trade Commission Tuesday, the panelists agreed to reclassify all drug...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK